Innovation
“Early testing can avert disaster, but false positives are stressful and costly. Now there’s a solution…from a company called Cardiac Insight.”
Wall Street Journal, March 3, 2017
Cardea 20/20 ECG™ is the only device automated with the Refined Seattle Criteria, now evolving into the International Criteria for ECG Interpretation in Athletes.
Co-authored by Cardiac Insight’s Dr. Victor Froelicher • DOWNLOAD NEW CRITERIA
Solutions to Unmet Clinical Needs
Cardiac Insight develops advanced body-worn sensing and computing technologies for cardiac diagnostics that uniquely enhance clinical efficacy to the benefit of patients, physicians and clinicians.
